Li S, Xia S, Lawas M, Kulshreshtha A, Garb B, Perera A
bioRxiv. 2025; .
PMID: 39896613
PMC: 11785119.
DOI: 10.1101/2025.01.17.633627.
Blanco R, Munoz J
Viruses. 2024; 16(11).
PMID: 39599814
PMC: 11599080.
DOI: 10.3390/v16111699.
Yongprayoon V, Wattanakul N, Khomate W, Apithanangsiri N, Kasitipradit T, Nantajit D
Oncol Rep. 2024; 51(6).
PMID: 38606512
PMC: 11040537.
DOI: 10.3892/or.2024.8733.
Rosendo-Chalma P, Antonio-Vejar V, Ortiz Tejedor J, Ortiz Segarra J, Vega Crespo B, Bigoni-Ordonez G
Biology (Basel). 2024; 13(2).
PMID: 38392296
PMC: 10886769.
DOI: 10.3390/biology13020077.
Li X, Wei X, Liu X, Wang N, Xu F, Liu X
BMC Cancer. 2023; 23(1):1052.
PMID: 37914994
PMC: 10621124.
DOI: 10.1186/s12885-023-11538-2.
Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases.
Zygouras I, Leventakou D, Pouliakis A, Panagiotou S, Tsakogiannis D, Konstantopoulos G
Int J Mol Sci. 2023; 24(19).
PMID: 37834041
PMC: 10572864.
DOI: 10.3390/ijms241914593.
Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications.
Castro-Oropeza R, Pina-Sanchez P
Front Genet. 2022; 13:886613.
PMID: 35774512
PMC: 9237502.
DOI: 10.3389/fgene.2022.886613.
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
Mainguene J, Vacher S, Kamal M, Hamza A, Masliah-Planchon J, Baulande S
Mol Oncol. 2022; 16(16):3001-3016.
PMID: 35398964
PMC: 9394244.
DOI: 10.1002/1878-0261.13219.
Analysis of HPV Integrations in Mexican Pre-Tumoral Cervical Lesions Reveal Centromere-Enriched Breakpoints and Abundant Unspecific HPV Regions.
Garza-Rodriguez M, Oyervides-Munoz M, Perez-Maya A, Sanchez-Dominguez C, Berlanga-Garza A, Antonio-Macedo M
Int J Mol Sci. 2021; 22(6).
PMID: 33810183
PMC: 8005155.
DOI: 10.3390/ijms22063242.
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System.
Zhou C, Tuong Z, Frazer I
Front Oncol. 2019; 9:682.
PMID: 31428574
PMC: 6688195.
DOI: 10.3389/fonc.2019.00682.
Human Papillomavirus Type 16 Mutations Associated with Cervical Cancer in a Han Chinese Population.
Yao Y, Yan Z, Dai S, Li C, Yang L, Liu S
Int J Med Sci. 2019; 16(7):1042-1049.
PMID: 31341418
PMC: 6643129.
DOI: 10.7150/ijms.34279.
Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato F, Amaro-Filho S, Moreira M, Cavalcanti S
Mem Inst Oswaldo Cruz. 2018; 114:e180456.
PMID: 30569945
PMC: 6319029.
DOI: 10.1590/0074-02760180456.
Oxidative stress in female cancers.
Calaf G, Urzua U, Termini L, Aguayo F
Oncotarget. 2018; 9(34):23824-23842.
PMID: 29805775
PMC: 5955122.
DOI: 10.18632/oncotarget.25323.
Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology.
Gonzalez-Losa M, Puerto-Solis M, Tenorio Ruiz J, Rosado-Lopez A, Hau-Aviles O, Ayora-Talavera G
Mem Inst Oswaldo Cruz. 2016; 111(12):770-773.
PMID: 27812600
PMC: 5146739.
DOI: 10.1590/0074-02760160269.
Comparative study of HPV16 integration in cervical lesions between ethnicities with high and low rates of infection with high-risk HPV and the correlation between integration rate and cervical neoplasia.
Han L, Maimaitiming T, Husaiyin S, Wang L, Wusainahong K, Ma C
Exp Ther Med. 2015; 10(6):2169-2174.
PMID: 26668611
PMC: 4665317.
DOI: 10.3892/etm.2015.2740.
Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation.
Chalertpet K, Pakdeechaidan W, Patel V, Mutirangura A, Yanatatsaneejit P
Cancer Sci. 2015; 106(10):1333-40.
PMID: 26250467
PMC: 4638020.
DOI: 10.1111/cas.12761.
Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil.
Tavares M, Macedo J, Lima Junior S, Heraclio S, Ramos Amorim M, Maia M
Mol Biol Rep. 2014; 41(2):865-74.
PMID: 24395291
DOI: 10.1007/s11033-013-2927-2.
A review of methods for detect human Papillomavirus infection.
Abreu A, Souza R, Gimenes F, Consolaro M
Virol J. 2012; 9:262.
PMID: 23131123
PMC: 3507852.
DOI: 10.1186/1743-422X-9-262.
A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter.
Gao C, Pan M, Lei Y, Tian L, Jiang H, Li X
BMC Mol Biol. 2012; 13:5.
PMID: 22333459
PMC: 3307029.
DOI: 10.1186/1471-2199-13-5.
Correlation between physical status of human papilloma virus and cervical carcinogenesis.
Li K, Jin X, Fang Y, Wang C, Gong M, Chen P
J Huazhong Univ Sci Technolog Med Sci. 2012; 32(1):97-102.
PMID: 22282253
DOI: 10.1007/s11596-012-0017-7.